Investigation of DHA Intake in Pregnant and Lactating Women in China
Studie Overzicht
Toestand
Gedetailleerde beschrijving
This is a multi-center, cross-sectional, non-interventional, observational study in 816 pregnant (gestation week 17±2 group and gestation week 39±2 group 408 cases in each group) and 408 lactating women (post-natal lactation day 42±7 group) from a total of 4 sites in 3 typical areas (1 coastal regions, 2 inland regions and 1 lake regions) in China to study the correlation between DHA intake and DHA concentrations in blood and breast milk. Investigators are mainly physicians majoring in gynaecology and obstetrics, etc. During visits, the study physician will record the patient's social demographic data, disease and relevant medication history, review her medical records, assess DHA intake by the DHA Screener, and determine DHA concentrations in erythrocyte membrane, plasma and breast milk, so as to validate the feasibility of DHA Screener as DHA intake assessment tool for determining DHA concentrations in the body.
Subjects meeting inclusion criteria and non of the exclusion criteria will be informed of relevant information of the study. Subjects should be voluntarily consent to participate in the study and sign the informed consent form.
Screening of the study is scheduled for as long as 5 months. In this study, additional examinations or other interventions are not required.
Studietype
Inschrijving (Werkelijk)
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
PREGNANT WOMEN:
- Healthy women presenting at their week 17±2 and week 39±2 obstetric examination;
- 18-40 years of age;
- Monocyesis;
- Having signed the informed consent form voluntarity before participating in the study.
LACTATING WOMEN:
- Healthy women presenting at their day 42±7 post-natal visit;
- 18-40 years of age;
- Monocyesis;
- Having signed the informed consent form voluntarily before participating in the study
Exclusion Criteria:
- Administration of DHA supplements (milk powder for pregnant women, DHA soft capsule, Zmarto, NURIZ, Naturies, HeadDHA, Beibeicong, Nutrimed etc);
- Still experiencing severe vomiting after 16 weeks of pregnancy;
- Women who have heart, liver, kidney, (ALT and AST≥ 1.5 times of normal upper limit, Cr>normal upper limit) or severe lung disease or laboratory abnormality (i.e.lipid metabolism disorder) that may interfere with the interpretation of study results, as indicated in previous examinations;
- Pregnant woman currently participating in other clinical trials or who have participated in another clinical trial in the last 30 days;
- Women who in the judgement of the investigator cannot be expected to comply with the protocol or study procedures.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
To evaluate the feasibility in using DHA Screener for determination of internal DHA concentration
Tijdsspanne: 5 months
|
Correlation between DHA Screener and DHA concentration in plasma; Correlation between DHA Screener and DHA concentration in erythrocyte membrane; Correlation between DHA Screener and DHA concentration in breast milk.
|
5 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
To compare the correlation between DHA Screener and RBC DHA among different subgroups. To compare DHA intake assessed by DHA Screener against Chinese recommendations of DHA intake.
Tijdsspanne: 5 months
|
|
5 months
|
|
To compare DHA intake assessed by DHA Screener against Chinese recommendations of DHA intake.
Tijdsspanne: 5 months
|
To compare DHA intake assessed by DHA Screener against Chinese recommendations of DHA intake.
|
5 months
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
To assess the correlation between DHA intake and DHA concentrations in the blood and breast milk of lactating women
Tijdsspanne: 5 months
|
To assess the correlation between DHA intake and DHA concentrations in the blood and breast milk of lactating women
|
5 months
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie stoel: Jianmeng Liu, Doctor, Peking University
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- 14.10.CN.INF
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .